Publication|Articles|March 14, 2025
- Pharmaceutical Executive: March 2025
- Volume 45
- Issue 2
Pharmaceutical Executive: March 2025 Interactive Digital Edition
View the Pharmaceutical Executive March 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
9 months ago
High Impact9 months ago
Mark Frohlich: A ‘Natural’ Leader9 months ago
FDA’s New Accelerated Approval Draft GuidanceNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Brent Saunders: Eyeing New Horizons
2
TrumpRX Has a Blind Spot and It Can Redefine Patient Access
3
Lilly’s Retatrutide Displays Positive Topline Results in Successful Phase III Trial
4
FDA Approves Amgen's Uplizna for Generalized Myasthenia Gravis With Positive AChR or MuSK Antibodies
5
